Related Experiment Video
Updated: Feb 27, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis
Burak Yazgan1, Erdi Sozen1, Betul Karademir1
1Department of Biochemistry, Faculty of Medicine, Genetic and Metabolic Diseases Research Center (GEMHAM), Marmara University, Maltepe, Istanbul, 34854, Turkey.
Insights
Increased serum cholesterol drives atherosclerosis by promoting foam cell formation via CD36. This study shows CD36 mRNA in blood cells mirrors aortic CD36 levels, suggesting it as a biomarker for atherosclerosis burden.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Molecular Biology
Background:
- Atherosclerosis is a complex disease influenced by genetics and environment.
- Elevated cholesterol and oxidized low-density lipoprotein (ox-LDL) are key triggers.
- CD36 receptor-mediated ox-LDL uptake by mononuclear cells is crucial for foam cell formation and atherogenesis.
Purpose of the Study:
- To investigate if CD36 expression in peripheral blood mononuclear cells (PBMCs) reflects aortic tissue levels in hypercholesterolemia.
- To establish PBMCs as a potential biomarker for atherosclerotic burden.
Main Methods:
- Immunohistochemistry of aortic specimens in hypercholesterolemic animal models.
- Analysis of CD36, HNE-protein adducts, smooth muscle actin, and vimentin expression.
- RT-PCR to determine CD36 mRNA expression in PBMCs and aorta of rabbits and humans.
Main Results:
- Hypercholesterolemia significantly increased CD36 protein and related markers (HNE-protein adducts, smooth muscle actin, vimentin) in the aorta.
- High cholesterol diet induced CD36 mRNA expression in both rabbit aorta and PBMCs.
- A positive correlation was found between aortic and PBMC CD36 expression.
- Human PBMCs from hypercholesterolemic individuals showed significantly higher CD36 mRNA levels than normocholesterolemic individuals.
Conclusions:
- CD36 mRNA levels in PBMCs can serve as a reliable indicator of CD36 expression in aortic tissue.
- PBMC CD36 mRNA levels show potential as a non-invasive biomarker for diagnosing atherosclerotic burden.
Abstract:
Together with complex genetic and environmental factors, increased serum cholesterol and ox-LDL levels are considered as major triggering factors of atherosclerosis. Mononuclear cell infiltration to the arterial wall and uptake of ox-LDL, which is facilitated by CD36 receptor through an uncontrolled manner, play a key role in foam cell formation followed by atherogenesis development. The aim of this study was to analyze if CD36 expression in peripheral blood mononuclear cells reflect its aortic tissue level in hypercholesterolemia. In this study, CD36 protein expression was evaluated in aortic specimens of cholesterol or cholesterol plus Vitamin E treated animals in relation to the immunohistochemical analyses for the HNE-protein adducts, as well as for smooth muscle actin and vimentin. The CD36 mRNA expression was determined by RT-PCR in PBMC of hypercholesterolemic rabbits and hypercholesterolemic versus normocholesterolemic individuals. Immunohistochemistry findings revealed that smooth muscle actin, smooth muscle vimentin, HNE-protein conjugates, and CD36 protein expressions were significantly increased in aorta of hypercholesterolemic group where foam cells were present. High cholesterol diet significantly induced CD36 mRNA expression in both rabbit aorta and PBMCs, while positive correlation between aortic and PBMC CD36 expression has been found. In addition, consistent with the rabbit model, CD36 mRNA expression levels in human PBMCs were significantly higher in hypercholesterolemic patients than in normocholesterolemic individuals. Taken together, these results demonstrate that the CD36 mRNA levels of PBMCs could reflect the CD36 mRNA levels in aorta and could be used as a biomarker for diagnosis of atherosclerotic burden. © 2018 BioFactors, 44(6):588-596, 2018.
Related Concept Videos
Inflammation
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology

